Cargando…
Comparison of Long-term Outcomes in Patients with Premature Triple-vessel Coronary Disease Undergoing Three Different Treatment Strategies: A Prospective Cohort Study
BACKGROUND: Patients with premature triple-vessel disease (PTVD) have a higher risk of recurrent coronary events and repeat revascularization; however, the long-term outcome of coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), and medical therapy (MT) alone for PTVD p...
Autores principales: | Xu, Jing-Jing, Zhang, Yin, Jiang, Lin, Tian, Jian, Song, Lei, Gao, Zhan, Feng, Xin-Xing, Zhao, Xue-Yan, Zhao, Yan-Yan, Wang, Dong, Sun, Kai, Xu, Lian-Jun, Liu, Ru, Gao, Run-Lin, Xu, Bo, Yuan, Jin-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754943/ https://www.ncbi.nlm.nih.gov/pubmed/29271373 http://dx.doi.org/10.4103/0366-6999.221273 |
Ejemplares similares
-
Effect of NPC1L1 and HMGCR Genetic Variants With Premature Triple-Vessel Coronary Disease
por: Zhao, Xueyan, et al.
Publicado: (2021) -
Susceptible gene polymorphism in patients with three-vessel coronary artery disease
por: Liu, Ru, et al.
Publicado: (2020) -
Direct Bilirubin Levels Predict Long-Term Outcomes in Patients With Acute Coronary Syndrome Under Different Glucose Metabolism Status: A 6.5-Year Cohort Study of Three-Vessel Disease
por: Liu, Yue, et al.
Publicado: (2021) -
HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins
por: Li, Jiawen, et al.
Publicado: (2023) -
Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention
por: Jiang, Ping, et al.
Publicado: (2019)